City

Seongnam (1)

Seoul (1)

Condition

Glaucoma (2)

Ocular Hypertensive (2)

Overall Status

Active, not recruiting (1)

Completed (1)

Sign in for free

Phase

phase 4 (2)

Sponsor

CHA University (2)

Collaborator

Hanlim Pharm. Co., Ltd. (2)

Intervention

bridin-plus eye drops (1)

brimonidine tartrate 1.5mg (1)

combigan eye drops (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Other (2)

Study Type

Interventional (2)

ocular hypertensive

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Glaucoma, Ocular Hypertensive Trial in Seoul (BRIDIN-plus Eye drops, Combigan Eye drops)

Completed

Glaucoma
Ocular Hypertensive

BRIDIN-plus Eye drops
Combigan Eye drops

Seoul, Seongnam, Bundang-gu, Korea, Republic of

Seungsoo Rho

Oct 9, 2023

Glaucoma, Ocular Hypertensive Trial in Seongnam (Brimonidine Tartrate 1.5mg)

Active, not recruiting

Glaucoma
Ocular Hypertensive

Brimonidine Tartrate 1.5mg

Seongnam, Bundang-gu, Korea, Republic of

CHA University Bundang Medical Center

Nov 23, 2020